Moreover, TME of DLBCL with PD-L1 up-regulation is accompanied by substantial T-lymphocyte infiltration, and such patients are more responsive to PD-1 inhibitors, as observed in patients with r/rDLBCL (Godfrey et al., 2018). This evidence concerns the gene PDCD1 and diffuse large B-cell lymphoma.